跳到正文
原文
Nature 健康护理主题·· 2026-10-16精选AI 评分64

英格兰头颈癌治疗等待时间及其决定因素:基于真实世界数据的群体队列研究

Waiting times and determinants of delay for head and neck cancer in England—a population cohort study using real world data

AI 导读

一项发表于《英国癌症杂志》的研究利用英格兰国家数据库分析了30,506名头颈癌患者的治疗等待时间,发现43%的患者经历了超过62天的治疗延误,其中11%接受初始手术和20%接受初始(化学)放疗的患者延误超过90天。多变量分析显示,非紧急转诊是长延误的最强预测因素(aOR 4.07),其他风险因素包括在非专科医院初次评估、非口咽癌以及较高的社会经济剥夺程度。

推荐理由

基于英格兰3万例头颈癌患者数据,识别出非紧急转诊是影响治疗延误的最强预测因素。

正文 · 原文
  • Article
  • Published: 16 October 2026

Epidemiology

British Journal of Cancer (2026) Cite this article

Abstract

Background

In Head and Neck Cancer (HNC), even short delays in treatment can worsen prognosis. We used real-world data to quantify waiting times and identify patient, tumour and health service factors associated with treatment delay in England.

Methods

Using linked national datasets (Cancer Registry, Cancer Waiting Times, Hospital Episodes Statistics, Radiotherapy and Chemotherapy), we calculated waiting times from referral to first treatment (surgery or (chemo)radiation) and used multivariable logistic regression models to examine factors associated with delay.

Results

Of 30,506 patients, 43% experienced treatment delay ( > 62 days from referral). Long delays ( > 90 days) affected 11% of patients treated with primary surgery and 20% of those receiving primary (chemo)radiation. Non-urgent referral (30% of patients) was the strongest predictor of long delay (aOR 4.07, CI: 3.54–4.68). Additional risk-factors included initial assessment at non-specialist (spoke) hospitals, non-oropharyngeal cancers, and higher socio-economic deprivation.

Conclusions

Treatment delays in HNC are worsening, particularly for patients treated with primary (chemo)radiation. Referral route is the strongest determinant. Interventions should focus on optimising referral pathways, increasing awareness of HNC symptoms among the public and primary care, and acknowledging the different drivers of delay associated with surgery and (chemo)radiation therapy.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 24 print issues and online access

251,40 € per year

only 10,48 € per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

39,95 €

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Data availability

The data used in this study was provided by NHS Digital National Disease Registration Request (NDRS) under license for the current study. We do not have permission to share this data.

Code availability

All analyses were conducted in RStudio (2024.09.0). Code is not currently available as the work is ongoing and the underlying data are subject to access restrictions.

References

  1. BBC. The cancers with longest treatment waits revealed. 2024. Available from: https://www.bbc.co.uk/news/articles/cwy948p4j5wo

  2. Cancer Research UK. 2025. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/head-and-neck-cancers

  3. Xiao R, Ward MC, Yang K, Adelstein DJ, Koyfman SA, Prendes BL, et al. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: a mechanism for increased mortality. Cancer. 2018;124:1400–14.

    Article  PubMed  Google Scholar 

  4. Cancer Research UK: Public Opinion Polling Survey: Key Findings from 2023.; 2023. Available from: https://news.cancerresearchuk.org/2024/07/15/cancer-is-the-uk-publics-biggest-health-concern/

  5. Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34:169–78.

    Article  CAS  PubMed  Google Scholar 

  7. Graboyes EM, Kompelli AR, Neskey DM, Brennan E, Nguyen S, Sterba KR, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145:166–77.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  9. Seoane J, Takkouche B, Varela-Centelles P, Tomas I, Seoane-Romero JM. Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis. Clin Otolaryngol. 2012;37:99–106.

    Article  CAS  PubMed  Google Scholar 

  10. Cancer Research UK NDRS. Which cancer patients experience long waits to treatment, and why? Analysis of patients waiting over 104 days from urgent suspected cancer referral to first cancer treatment in England, for 2017/2018, 2020/2021, 2021/2022 and 2022/2023; 2024. Available from: https://assets.ctfassets.net/u7vsjnoopqo5/7y1sDXBJSadpee8dH0E6fu/6fdd5480869b067ba7d788120bc5dae3/long_waiters_report_24.pdf

  11. Schoonbeek RC, Zwertbroek J, Plaat BEC, Takes RP, Ridge JA, Strojan P, et al. Determinants of delay and association with outcome in head and neck cancer: a systematic review. Eur J Surg Oncol. 2021;47:1816–27.

    Article  PubMed  Google Scholar 

  12. Zhang J, Venchiarutti R, Wang X, He Q. Optimal timing of cancer treatments: a call for emerging evidence from clinical trials and real-world studies. Br J Cancer. 2025;132:1085–90.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jiang JX, Pan WW, Sun LY, Pang LW, Chen HL, Huang J, et al. Real-world data and evidence: pioneering frontiers in precision oncology. J Zhejiang Univ-Sc B. 2026;27:44–57.

    Google Scholar 

  14. Walter F, Webster A, Scott S, Emery J. The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy. 2012;17:110–8.

    Article  PubMed  Google Scholar 

  15. Office for Health Improvement & Disparities. Atlas of health variation in head and neck cancer in England. 2024. Available from: https://www.gov.uk/government/statistics/atlas-of-health-variation-in-head-and-neck-cancer-in-england

  16. Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, et al. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer. 2015;121:1204–13.

    Article  PubMed  Google Scholar 

  17. Sorensen J. Centralisation of oncology surgery services. Lancet Oncol. 2022;23:1119–21.

    Article  PubMed  Google Scholar 

  18. Mungall IJ. Trend towards centralisation of hospital services, and its effect on access to care for rural and remote communities in the UK. Rural Remote Health. 2005;5:390.

    PubMed  Google Scholar 

  19. Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, et al. Diagnosis of cancer as an emergency: a critical review of current evidence. Nat Rev Clin Oncol. 2017;14:45–56.

    Article  PubMed  Google Scholar 

  20. Tope PR, Goncalves BP, El-Zein M, Franco EL. The health related impact of disruptions in cancer care and the Waiting Time Paradox. Am J Epidemiol. 2025.

  21. Bradley PT, Lee YK, Albutt A, Hardman J, Kellar I, Odo C, et al. Nomenclature of the symptoms of head and neck cancer: a systematic scoping review. Front Oncol. 2024;14.

  22. Albutt A, Hardman J, Mcvey L, Odo C, Paleri V, Patterson J, et al. Qualitative study exploring the design of a patient-reported symptom-based risk stratification system for suspected head and neck cancer referrals: protocol for work packages 1 and 2 within the EVEREST-HN programme. BMJ Open. 2024;14.

  23. National Institute for Health and Social Care Research. Evolution of a patiEnt-REported symptom-based risk stratification sySTem to redesign the suspected Head and Neck cancer referral pathway (EVEREST-HN). 2022. Available from: https://www.fundingawards.nihr.ac.uk/award/NIHR202862

  24. Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19:306–27.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Blanchard P, Garden AS. Looking beyond the numbers: highlighting the challenges of population-based studies in cancer research. J Clin Oncol. 2016;34:2317–8.

    Article  CAS  PubMed  Google Scholar 

  26. Sorensen JR, Johansen J, Gano L, Sorensen JA, Larsen SR, Andersen PB, et al. A “package solution” fast track program can reduce the diagnostic waiting time in head and neck cancer. Eur Arch Oto-Rhino-L. 2014;271:1163–70.

    Article  Google Scholar 

  27. NHS England. Implementing a timed head and neck cancer diagnostic pathway. Available from: https://www.england.nhs.uk/wp-content/uploads/2018/04/B1130-head-and-neck-cancer-implementing-a-timed-diagnostic-pathway-07-06-2024.pdf

  28. Cancer Research UK. Cancer in the UK: Overview 2025. 2025. Available from: https://www.cancerresearchuk.org/health-professional/our-reports-and-publications/cancer-in-the-uk-overview

Download references

Acknowledgements

We would like to thank the team and network collaborators at the International Centre for Recurrent Head and Neck Cancer (IReC) for their ongoing support with this article and our wider program of research. Many thanks in particular to Andrew Williamson and Justin Weir within IReC, Amanda McDonnell, Emily Mayne & Andrew Hutchings at the National Cancer Audit Collaborating Centre, and Jing Song at LSHTM for their assistance on this project. ChatGPT (OpenAI, 2025) was used to assist with identifying appropriate packages in RStudio and troubleshooting programming code. All scripts were reviewed and verified by authors.

Funding

This study was funded by the International Centre for Recurrent Head and Neck Cancer (IReC), based at the Royal Marsden Hospital.

Author information

Author notes

  1. These authors contributed equally: Kate Walker, Vinidh Paleri.

Authors and Affiliations

  1. International Centre for Recurrent Head and Neck Cancer, Royal Marsden Hospital NHS Foundation Trust, London, UK

    Farizeh Jashek-Ahmed & Vinidh Paleri

  2. Head and Neck Unit, Royal Marsden Hospital NHS Foundation Trust, London, UK

    Farizeh Jashek-Ahmed & Vinidh Paleri

  3. Department of Health Services Research & Policy, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK

    Farizeh Jashek-Ahmed, Orouba Almilaji, Thomas E. Cowling & Kate Walker

  4. Academic Centre for Healthy Ageing (ACHA), Wolfson Institute of Population Health, Queen Mary University of London, London, UK

    Orouba Almilaji

  5. Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK

    Thomas E. Cowling & Kate Walker

  6. Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK

    Thomas E. Cowling

  7. Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK

    David W. Hamilton

  8. Otolaryngology Department, Newcastle-Upon-Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK

    David W. Hamilton

  9. The Institute of Cancer Research, London, UK

    Vinidh Paleri

Authors

  1. Farizeh Jashek-Ahmed
  2. Orouba Almilaji
  3. Thomas E. Cowling
  4. David W. Hamilton
  5. Kate Walker
  6. Vinidh Paleri

Contributions

Conceptualization: all authors; Methodology: FJA, VP, KW, TC, OA; Data curation: FJA, OAM; Formal Analysis: FJA; Writing—original draft: FJA; Writing—Review and Editing: all authors; Supervision: VP, KW, TC; Funding acquisition: VP, KW.

Corresponding author

Correspondence to Farizeh Jashek-Ahmed.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Ethics approval and consent to participate

This research was approved by the London School of Hygiene and Tropical Medicine Ethics Committee (ref 27459).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jashek-Ahmed, F., Almilaji, O., Cowling, T.E. et al. Waiting times and determinants of delay for head and neck cancer in England—a population cohort study using real world data. Br J Cancer (2026). https://doi.org/10.1038/s41416-026-03630-8

Download citation

  • Received: 26 September 2025

  • Revised: 27 August 2026

  • Accepted: 10 September 2026

  • Published: 16 October 2026

  • Version of record: 16 October 2026

  • DOI: https://doi.org/10.1038/s41416-026-03630-8

来源:Nature 健康护理主题 · nature.com